SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001415889-16-005393
Filing Date
2016-03-30
Accepted
2016-03-30 16:54:44
Documents
65
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K fpmi10k_dec312015.htm 10-K 1431060
2 CONSENT OF WOLF & COMPANY, P.C. ex23-1.htm EX-23.1 2691
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14 OF THE SECURITI ex31-1.htm EX-31.1 9435
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14 OF THE SECURITI ex31-2.htm EX-31.2 10002
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 1350. ex32-1.htm EX-32.1 4690
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 1350. ex32-2.htm EX-32.2 5169
  Complete submission text file 0001415889-16-005393.txt   4845336

Data Files

Seq Description Document Type Size
7 fpmi-20151231.xml EX-101.INS 770010
8 fpmi-20151231.xsd EX-101.SCH 66366
9 fpmi-20151231_cal.xml EX-101.CAL 47368
10 fpmi-20151231_def.xml EX-101.DEF 101383
11 fpmi-20151231_lab.xml EX-101.LAB 379226
12 fpmi-20151231_pre.xml EX-101.PRE 259156
Mailing Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042
Business Address 8 HILLSIDE AVENUE SUITE 207 MONTCLAIR NJ 07042 973-744-1565
FLUOROPHARMA MEDICAL, INC. (Filer) CIK: 0001402785 (see all company filings)

IRS No.: 208325616 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-147193 | Film No.: 161540408
SIC: 2835 In Vitro & In Vivo Diagnostic Substances